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We have previously demonstrated the role of hepatitis C virus (HCV) core protein in the transcriptional regulation of
cellular and unrelated viral promoters. Furthermore, the core protein in cooperation with H-ras oncogene transforms primary
rat embryo fibroblast cells to the tumorigenic phenotype. In the present study, the functional role of HCV core protein was
investigated to determine its potential to inhibit the onset of apoptotic cell death. Expression of HCV core protein inhibited
cisplatin mediated apoptosis in human cervical epithelial cells, and apoptosis induced by the overexpression of c-myc in
Chinese hamster ovarian cells. Results from these studies suggest that the core protein may have a biological implication
in the pathogenesis of HCV infection. q 1996 Academic Press, Inc.
INTRODUCTION by the blocking of E2 binding to cells, whereas in infec-
tion such antibodies are at low levels or are absent (Rose
Hepatocellular carcinoma (HCC) is among the most et al., 1996). The extent to which cellular immunity oper-
common malignant tumors worldwide. While it has long ates as a mechanism of protective immunity against HCV
been recognized that the development of HCC is strongly is still undefined (Erickson et al., 1993).
associated with chronic hepatitis B viral (HBV) infection, HCV contains a single-stranded positive sense RNA
it has only been recently noted that a similar association genome of approximately 10 kb in length which encodes
may be evident with hepatitis C virus (HCV) infection (Di a polypeptide precursor of 3000 amino acids. The pre-
Bisceglie, 1995). This recognition has resulted from the cursor polypeptide is cleaved into its functional units by
development of sensitive and specific assays to detect both viral and host proteases, producing at least nine
HCV infection (Choo et al., 1989; Kuo et al., 1989). Com- distinct polypeptides from these cleavage events. The
pelling data indicate that as many as 90% of infected putative structural proteins, core, E1, and E2 (p7), are
individuals do not resolve their infection and become located in the amino-terminal quarter of the viral precur-
lifelong chronic carriers of HCV, causing a significant sor and are proteolyticaly cleaved by host signalases
number of deaths per year (The Jordan Report, 1995). localized to the endoplasmic reticulum; and the nonstruc-
Individuals may show no overt symptoms of hepatitis, but tural proteins are processed by HCV-specific proteinases
some infected persons progress to cirrhosis and HCC. (Hijikata et al., 1991; Grakoui et al., 1993a,b; Selby et al.,
Understanding the viral basis for HCV persistence in the 1993). The core protein is relatively conserved among all
face of a polyclonal humoral and cellular immune re- identified HCV isolates (Bukh et al., 1994). The carboxyl-
sponse is a major challenge (Cerny and Chisari, 1994). terminus of the core protein has been established to be
This must be met in order to understand the immunobiol- at amino acid position 191 (Hijikata et al., 1991). HCV
ogy and pathogenesis of, and to permit the rational de- has a replicative cycle that most likely takes place in the
sign of effective strategies for the prevention and treat- cytoplasm. The core protein may be the fundamental unit
ment of, this serious infection. The majority of HCV-in- for encapsidation of genomic RNA to help in virus mor-
fected humans show evidence of an antibody response phogenesis. However, nuclear localization of the core
to the E1 and E2 glycoproteins (Chien et al., 1993; Ray protein (Shih et al., 1993; Lo et al., 1995) raises questions
et al., 1994). However, the generation of isolate-specific concerning its further biological significance. A trans-
neutralizing antibody responses and serotypic variation regulatory function of the core protein on cellular and
are probably significant features of HCV infection (Farci viral promoters has previously been observed (Shih et
et al., 1994; Purcell, 1994). Recent studies suggest that al., 1993; Ray et al., 1995). Furthermore, the core protein
vaccination can induce high antibody titers as measured in cooperation with H-ras transforms primary rat embryo
fibroblasts to the tumorigenic phenotype (Ray et al.,
1996), potentially implicating its biological role in the de-1 To whom correspondence and reprint requests should be ad-
velopment of HCC.dressed at Division of Infectious Diseases and Immunology, Saint Louis
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hibit this mechanism (White, 1996). Recent evidence sug- protein in the inhibition of cellular apoptosis. An external
causative agent such as UV light or cisplatin, an antican-gests that alterations in cell survival contribute to the
pathogenesis of a number of human diseases, including cer agent, have been shown to induce an apoptotic re-
sponse (Zhu et al., 1995; Fritsche et al., 1993) in a mannerviral oncogenesis (Thompson, 1995). In the present
study, we investigated the functional role of HCV core which facilitates the study of this phenomenon and its
regulation. Initial analyses to determine the extent of HCVprotein in the abrogation of apoptotic cell death mediated
by a number of established stimuli. Our results demon- core-mediated regulation of apoptosis were carried out
utilizing core-expressing HeLa cells as the experimentalstrate that HCV core protein suppresses cisplatin- and
c-myc-mediated apoptosis and may have a role in the and vector DNA transfected cells as the positive control
following treatment with cisplatin or by UV irradiation.establishment of persistent infection.
Briefly, 2 1 105 cells were plated onto 35-mm dishes
MATERIALS AND METHODS 20 hr prior to treatment with cisplatin. After the cells were
exposed to cisplatin for a predetermined length of time,Cell culture
adherent and nonadherent cells were collected for analy-
Human cervical carcinoma cells (HeLa) were obtained ses of apoptotic cell death (Ray, 1995).
from the American Type Culture Collection. A primary The aberrant overexpression of c-myc in CHO cells
baby rat kidney cell line cotransformed with a ts mutant results in apoptotic cell death (Bissonnette et al., 1992).
of p53 (p53val135) and adenovirus E1A (BRK/p53val135- To determine whether the core protein could prevent
E1A) was kindly provided by G. Chinnadurai (Institute for apoptosis induced by the overexpression of c-myc, stable
Molecular Virology, Saint Louis University, St. Louis, MO). transfectants of 5A100 cells expressing the core protein
Cells were grown in Dulbecco’s modified Eagle’s medium were utilized. The effect of HCV core gene on c-myc
supplemented with 10% heat-inactivated fetal calf serum protein expression in transfected cells was also deter-
(FCS). Chinese hamster ovary (CHO) cells overex- mined by Western blot analysis using rabbit anti-mouse
pressing the mouse c-myc gene under the regulation of c-myc antibody (kindly provided by Douglas Green). The
a heat shock promoter (5A100) were kindly provided by control 5A100 cells or cells expressing HCV core protein
Douglas Green (La Jolla Institute for Allergy and Immu- were incubated at 437 in a water bath for various lengths
nology, La Jolla, CA) and were propagated in Iscove’s of time, followed by incubation in a CO2 incubator at 377.modified DMEM supplemented with 10% FCS, 2 mM L- Unless otherwise stated, adherent and nonadherent cells
glutamine, and 50 mM methotrexate. were collected after 24 hr to analyze the extent to which
apoptotic cell death has progressed.Plasmid construction and generation of HCV core
To investigate the involvement of p53, the BRK/expressing cell lines
p53val135-E1A was used. This cell line undergoes rapid
Amplification and cloning of HCV-1 core genomic se- and total apoptosis when the p53 protein assumes the
quences have been previously described (Lagging et al., wild-type conformation at 32.57. Inhibition of p53-medi-
1995). Briefly, the plasmid Blue4/C5p-1 (kindly provided ated apoptosis by HCV core protein was determined fol-
by M. Houghton, Chiron Corp., Emeryville, CA) was used lowing a similar methodology as described earlier (Su-
as a template in polymerase chain reaction (PCR) to am- bramanian et al., 1995). BRK/p53val135-E1A cells stably
plify the genomic region encoding the core protein transfected with the MuLV/core plasmid DNA or vector
(amino acids 1– 191) of HCV. The amplified DNA was DNA were tested for cell survival at 32.57. Trypan blue-
cloned into the pBabe/puro vector (Ray, 1995) under the excluding cells were counted to measure the starting
control of murine leukemia virus long terminal repeat viable cell number, while the rest of the dishes were
(MuLV/core) for expression of HCV core protein in cells. transferred to 32.57. Similar cell viability counts were
Subconfluent HeLa, 5A100 (Bissonnette et al., 1992), and taken at different time points.
BRK/p53val135-E1A (Subramanian et al., 1995) cells were
transfected with MuLV/core (experimental) or vector DNA
(control) using the lipofectamine reagent (Gibco BRL, Gaith- Analyses for apoptotic cell death
ersburg, MD). Puromycin-resistant stable transfectants
were selected and pooled. Cells were tested to confirm the The apoptotic response was monitored from cell viabil-
integration of HCV core gene and protein expression as ity by trypan blue exclusion and experiments were done
recently described (Ray et al., 1996). The cell lines express- in triplicate. DNA fragmentation was analyzed by agarose
ing HCV core protein were used to study its potential to gel electrophoresis following a procedure previously de-
inhibit the apoptotic response. scribed (Ray, 1995). A terminal deoxynucleotidyltransfer-
ase (TdT)-mediated dUTP nick end labeling (TUNEL)
Induction and abrogation of apoptotic cell death assay (Boehringer Manheim, IN) was also used for in situ
detection of DNA degradation following the supplier’sA number of treatments known to induce an apoptotic
response were utilized to examine the role of the core procedure.
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period, with a complete termination of the culture by
Day 3.
Endonucleolysis, a key biochemical event of apop-
tosis, results in the cleavage of nuclear DNA into apo-
ptotic signature oligonucleosome fragments. DNA from
vector transfected HeLa cells showed the characteristic
ladder formation which was not visible in the HCV core
gene transfected cells (figure not shown). TUNEL assay
was also used for in situ detection of DNA degradation
after 24 hr to monitor cellular apoptosis. Both vector DNA
and core gene transfected HeLa cells were visualized,
and the characteristic fluorescence is shown (Fig. 3).
Vector DNA transfected HeLa cells undergoing apoptotic
death retained fluorescein conjugated TdT in their de-
graded DNA strands, resulting in a bright fluorescence
(Fig. 3A), whereas stable transfectants of cells express-
ing HCV core protein did not exhibit detectable fluores-
cence (Fig. 3B). Results from this study suggested that
HeLa cells constitutively expressing HCV core protein
inhibit cisplatin-mediated apoptosis.
HCV core protein does not inhibit apoptosis induced
by UV irradiation
HeLa cells constitutively expressing core protein or
FIG. 1. Expression of HCV core protein in stably transfected HeLa transfected with the vector DNA were exposed to a num-
(A) and 5A100 (C) cells. Cells were tested for immunofluorescence by
ber of dosages of UV irradiation (5, 10, 20, or 40 J/m2) toanti-C22 antibody. Results from a similar analysis for immunofluoresc-
examine the ability of the core protein to antagonize theing vector transfected HeLa (B) and 5A100 (D) cells as negative controls
onset of UV-mediated apoptosis. In all cases, the consti-are shown.
tutive expression of HCV core protein was unable to
confer any significant protection from cell death. Monitor-
RESULTS
ing by trypan blue exclusion revealed no greater than a
5% increase in the number of viable cells expressingAbrogation of cisplatin-mediated apoptosis by HCV
core protein compared to vector DNA transfected con-core protein
trols. The appearance of oligonuclear fragments from
HeLa cells constitutively expressing HCV core as a
the vector DNA and HCV core transfected HeLa cells
nucleocytoplasmic protein (Figs. 1A and 1B) were used
indicated that the core protein conferred little or no pro-
to analyze the inhibition of cisplatin-mediated apoptosis.
tection from UV-mediated apoptosis (figure not shown).
Expression of the core protein in HeLa cells did not in-
duce a detectable change in the growth pattern com- Inhibition of c-myc-mediated apoptotis by HCV core
pared to the parental cell line. Initially, culture medium protein
containing different concentrations (10, 20, 30 or 40 mM)
of cisplatin were used to determine a dose-dependent To determine whether HCV core protein prevents c-
myc-mediated apoptosis, 5A100 cells overexpressing anresponse to the drug-induced cell death (Fig. 2A). In vec-
tor transfected positive control HeLa cells, significant cell amplified c-myc under the control of a heat shock pro-
moter (Bissonnette et al., 1992) were utilized. Vectordeath was apparent at cisplatin concentrations approxi-
mating 20 mM and above. In contrast, the core expressing transfected 5A100 cells were initially tested at various
times (30, 45, 60, or 75 min) for activation of the heatcell line exhibited the ability to inhibit the onset of
apoptosis at cisplatin concentrations reaching 30 mM. In shock promoter followed by incubation at 377 for approxi-
mately 24 hr. Cells heat induced for 60 min appeared tosubsequent experiments, cells were treated with 20 mM
cisplatin and the number of viable cells after successive offer the best results of c-myc-mediated apoptosis. The
5A100 cell line transfected with HCV core gene showeddays of incubation is shown (Fig. 2B). Significant viability
was maintained in HeLa cells constitutively expressing nucleocytoplasmic expression of the core protein (Figs.
1C and 1D). The difference in intensity of immunofluores-HCV core protein during the 3 days of the observation
period. As apparent from the given figure, the contiguous cence between 5A100 and HeLa cells (Figs. 1A and 1B)
may be due to the level of expression of the core proteinculture of vector transfected HeLa cells exhibited a rapid
decline in viable cell number throughout the incubation in these two different cell lines. The transfected 5A100
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FIG. 2. (A) Survival of vector DNA and HCV core gene transfected HeLa cells at 24 hr following treatment with different doses of cisplatin. (B)
Viability of HeLa cell transfectants following treatment with 20 mM cisplatin. Viable cells were counted by trypan blue exclusion up to 3 days from
the initiation of cisplatin treatment. HeLa cells expressing HCV core protein showed a significantly higher viability over the time of experiment
compared to the vector transfected cells.
cells did not show a detectable change in the growth characteristic DNA ladder formation exhibited by heat-
induced 5A100 cells (Fig. 5) indicates a level of protectioncharacteristics compared to the parental cell line. Subse-
quently, the stable transfectants and vector transfected conferred by the core protein.
5A100 cells were incubated at 437 for 60 min to activate
the heat shock promoter and induce the overexpression Test for the inhibitory role of HCV core protein in
of c-myc. At 24 hr postinduction, adherent and nonadher- p53-mediated cell death
ent cells were collected for a viable cell count and analy-
ses of genomic DNA oligonucleosomal fragmentation. p53 is a potent inducer of apoptosis, which contributes
to its function as a tumor suppressor gene (Lane, 1992;5A100 cells expressing HCV core protein showed 50%
higher cell viability than the vector transfected 5A100 Levine, 1993). p53-induced growth arrest and apoptosis
are well-known cellular responses to DNA damagingcells after 24 hr of c-myc induction (Fig. 4). Since the half-
life of c-myc is short, after heat induction its expression at agents, although several lines of evidence suggest that
p53-independent apoptotic pathways also exist (Hsu et5 hr in both HCV core gene transfected and vector DNA
transfected cells was tested using rabbit anti-mouse c- al., 1991; Strasser et al., 1994; Symonds et al., 1994). The
onset of apoptosis induced by cisplatin and overex-myc antibody by Western blot analysis and both cell
types showed a similar level of protein expression (figure pression of c-myc may occur through the accumulation
of the tumor suppressor protein, p53. To test the possibil-not shown). Thus, HCV core protein did not appear to
alter c-myc expression in the 5A100 stable transfectants. ity of p53 involvement, HCV core gene transfected BRK/
p53val135-E1A cells were tested for the inhibition ofIn the presence of HCV core protein, the absence of the
FIG. 3. Analysis of cisplatin (20 mM)-mediated apoptosis in HeLa cells by TUNEL assay. Vector transfected HeLa cells showed strong immunofluo-
rescence characteristic of DNA degradation (A) compared to the HeLa cells expressing HCV core protein (B).
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ing the Bcl-2 protein, blocking p53 function, inhibiting
the activity of interleukin-1b-converting enzyme family
members or upregulation of insulin-like growth factor II
(Subramanian et al., 1995; Wang et al., 1995; Ueda and
Ganem, 1996; Vaux and Strasser, 1996; White, 1996). The
pathology of HCV infection evolves around the develop-
ment of a chronic, persistent infection with the potential
for progression into HCC. The mechanism by which HCV
maintains viral persistence and promotes tumor forma-
tion in the liver is not at present understood.
Replication of HCV has been reported in a number of
mammalian cells including human primary hepatocytes
(Ito et al., 1996). However, efficient long-term virus repli-
cation has not been described in any system. In fact,
there is no report of successful purification of HCV for
biochemical analyses from either cultured cells or tis-FIG. 4. c-myc-induced apoptotic inhibition by HCV core protein in
5A100 cells. 5A100 cells expressing HCV core protein did not show sues of infected humans or experimental animals. It is
any major loss of cell viability after c-myc expression by heat induction. possible that HCV is stringently hepatotropic, being re-
On the other hand, 5A100 cells transfected with vector DNA showed stricted to replicate and release only in differentiated
a significant loss of cell viability following heat-induced c-myc expres-
hepatocytes, which may have HCV receptors on the cellsion.
surface and specific functions that support viral growth.
It is, therefore, difficult to study the biological properties
apoptosis. A difference in cell survival was not observed and pathogenicity of HCV. Consequently, in the absence
from p53-mediated apoptosis in the presence or absence of unequivocal evidence for a common ancestry, all infor-
of HCV core gene in BRK/p53val135-E1A cells under our mation about the mechanism of HCV replication at the
experimental conditions. This result suggested that the molecular level so far has depended on the comparative
HCV core protein exerts its antiapoptotic activity up- analysis and expression of its partial or entire genome
stream of the p53 pathway or independent of p53 activity. with those of distantly related flaviviruses or pestiviruses
(Suzuki et al., 1995; Zanotto et al., 1996). The chronicity
of HCV infections and the histopathologic findings indi-DISCUSSION
cate that the virus is probably not directly cytopathic (or
cytolytic) in hepatocytes (Shirai et al., 1994). In additionSince the HCV core protein modulates cellular promot-
ers at the transcriptional level and transforms primary to the potential role of core protein in the encapsidation
of HCV genomic RNA, it may have other biological func-rat embryo fibroblast cells in cooperation with the H-ras
oncogene to the tumorigenic phenotype, the ability of tions in an infected cell. Core protein is highly basic
this protein to inhibit the onset of apoptotic cell death
was considered. The results from this study demonstrate
the inhibitory role of the core protein with regard to cis-
platin- and c-myc-mediated apoptosis. Both cisplatin-
and c-myc-mediated apoptotic cell death may occur
through the accumulation of the tumor suppressor pro-
tein p53 (Lane, 1992; Wagner et al., 1994). However, the
core protein failed to protect apoptotic cell death medi-
ated either by UV irradiation or by p53 under our experi-
mental conditions.
Cells exposed to infectious agents initiate death pro-
grams as defensive mechanisms. The role of a number
of viral proteins in the induction or suppression of
apoptosis has been described. An adenovirus E1A-in-
duced apoptotic response is abrogated by E1B, thereby
sustaining viral persistence in the host (Rao et al., 1992).
FIG. 5. Analysis of DNA fragmentation in 5A100 cells. DNA fromThe IE1 and IE2 proteins of human cytomegalovirus block
uninduced (lane 2) and heat-induced (lane 4) vector transfected 5A100apoptosis and suggest their physiological role in the vi-
cells; and uninduced (lane 3) and heat-induced (lane 5) HCV core gene
rus replication cycle (Zhu et al., 1995). Several mecha- transfected 5A100 cells were analyzed by 1.5% agarose gel electropho-
nisms for the inhibition of apoptosis by viral proteins resis. The positions of fx174/HaeIII digest molecular size markers
(BRL) are shown (lane 1).have been suggested. These include mimicking or induc-
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